Clinical Trials Directory

Trials / Completed

CompletedNCT02149342

Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL

Daylight-mediated Photodynamic Therapy of Actinic Keratoses: a Randomized, Double-blinded Pilot Study Comparing Topical 0.2% Hexylaminolaevulinate With 16% Methylaminolaevulinate

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Joint Authority for Päijät-Häme Social and Health Care · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This pilot study compares two photosensitizers, hexylaminolaevulinate (HAL) and methylaminolaevulinate (MAL), in treatment of actinic keratoses. Study is conducted using randomized split-face design. Efficacy is assessed clinically, and histologically at 3 and 12 months. Pain during and after treatments and adverse reactions at one week are recorded.

Detailed description

Study recruites 16-20 voluuntering patients with symmetrical actinic damage on face or scalp. Treatment sites are randomized to receive either hexylaminolaevulinate 0.2% or methylaminolaevulinate ( 16% MAL) as photosensitizers (0.25mm-thick layer). A web-based validated program (Research Randomizer) generated a randomized list to define the treatment sides. The randomization results were kept blinded from the investigators who conducted the follow-up visits, from the pathologist, and the patients. Pre-treatment procedures include application of sunscreen for 15 minutes and curettage of the treatment area. Illumination is performed using 2 hours daylight-exposure. Efficacy is assessed clinically, and histologically at 3 and 12 months by blinded observers. Pain during and after treatments and adverse reactions at one week are recorded.

Conditions

Interventions

TypeNameDescription
DRUGHexylaminolaevulinate cream0.2% Hexylaminolaevulinate (Hexvix, Photocure) mixed with Unguentum M (Allmiral) cream (2014)
DRUGMethylaminolaevulinate creamMAL 16% is used as photosensitizer for daylight-PDT

Timeline

Start date
2014-05-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2014-05-29
Last updated
2016-07-11
Results posted
2016-07-11

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT02149342. Inclusion in this directory is not an endorsement.

Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL (NCT02149342) · Clinical Trials Directory